Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.120 | 2.120 | 0.000 |
Stocks | 97.880 | 97.880 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 12.622 | 16.172 |
Price to Book | 1.841 | 2.154 |
Price to Sales | 0.759 | 1.322 |
Price to Cash Flow | 6.725 | 10.239 |
Dividend Yield | 4.643 | 2.320 |
5 Years Earnings Growth | 8.243 | 12.740 |
Name | Net % | Category Average |
---|---|---|
Industrials | 33.040 | 28.178 |
Consumer Defensive | 18.100 | 7.696 |
Financial Services | 16.490 | 6.385 |
Healthcare | 11.530 | 18.665 |
Energy | 10.390 | 3.157 |
Consumer Cyclical | 5.810 | 11.871 |
Basic Materials | 4.650 | 4.901 |
Number of long holdings: 29
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sampo Oyj A | FI4000552500 | 9.32 | 38.87 | -0.99% | |
Novo Nordisk B | DK0062498333 | 7.11 | 632.3 | +0.37% | |
Valmet | FI4000074984 | 6.21 | 24.27 | +0.50% | |
Europris ASA | NO0010735343 | 5.56 | 74.05 | -0.13% | |
Loomis B | SE0014504817 | 5.44 | 340.00 | 0.00% | |
Danske Bank | DK0010274414 | 4.84 | 208.9 | +0.58% | |
HEXPOL B | SE0007074281 | 4.54 | 100.8 | -2.61% | |
Orkla | NO0003733800 | 4.53 | 100.40 | -1.67% | |
NCC B | SE0000117970 | 4.52 | 164.70 | 0.00% | |
Addtech | SE0014781795 | 4.32 | 287.80 | -0.90% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Holberg Global A | 7.23B | 33.23 | 12.61 | 14.68 | ||
Holberg Global C | 7.23B | 34.18 | 13.33 | 15.33 | ||
Holberg Global D | 7.23B | 34.01 | 13.28 | 15.31 | ||
Holberg Norge | 4.33B | 19.01 | 8.76 | 13.62 | ||
Holberg Triton A | 527.68M | 15.12 | 6.69 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review